These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29126849)

  • 21. Sulfonamide antibiotics inhibit RNAi by binding to human Argonaute protein 2 PAZ.
    Kitamura Y; Kandeel M; Kondo T; Tanaka A; Makino Y; Miyamoto N; Shibata A; Ikeda M; Kitade Y
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127637. PubMed ID: 33132114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
    Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
    FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-stranded siRNAs activate RNAi in animals.
    Lima WF; Prakash TP; Murray HM; Kinberger GA; Li W; Chappell AE; Li CS; Murray SF; Gaus H; Seth PP; Swayze EE; Crooke ST
    Cell; 2012 Aug; 150(5):883-94. PubMed ID: 22939618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA interference activity of single-stranded oligonucleotides linked between the passenger strand and the guide strand with an aryl phosphate linker.
    Koizumi M; Hirota Y; Nakayama M; Tamura M; Obuchi W
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(6):647-664. PubMed ID: 34047248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 2'-caged-tethered-siRNA shows light-dependent temporal controlled RNAi activity for GFP gene into HEK293T cells.
    Bollu A; Hassan MK; Dixit M; Sharma NK
    Bioorg Med Chem; 2021 Jan; 30():115932. PubMed ID: 33316720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties and synergistic effects of a nonionic backbone and aminoalkyl modified nucleosides in RNAs.
    Sawada H; Kakisawa Y; Ueno Y
    Bioorg Chem; 2024 Mar; 144():107143. PubMed ID: 38309000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of 3'-overhang to the dissociation of small interfering RNAs from the PAZ domain: molecular dynamics simulation study.
    Lee HS; Lee SN; Joo CH; Lee H; Lee HS; Yoon SY; Kim YK; Choe H
    J Mol Graph Model; 2007 Mar; 25(6):784-93. PubMed ID: 16959510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and gene silencing properties of siRNAs containing terminal amide linkages.
    Gaglione M; Mercurio ME; Potenza N; Mosca N; Russo A; Novellino E; Cosconati S; Messere A
    Biomed Res Int; 2014; 2014():901617. PubMed ID: 24791003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4'-
    Gangopadhyay S; Das G; Gupta S; Ghosh A; Bagale SS; Roy PK; Mandal M; Harikrishna S; Sinha S; Gore KR
    J Org Chem; 2024 Mar; 89(6):3747-3768. PubMed ID: 38394362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Analysis of Human Argonaute-2 Bound to a Modified siRNA Guide.
    Schirle NT; Kinberger GA; Murray HF; Lima WF; Prakash TP; MacRae IJ
    J Am Chem Soc; 2016 Jul; 138(28):8694-7. PubMed ID: 27380263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
    Kubo T; Yanagihara K; Sato Y; Nishimura Y; Kondo S; Seyama T
    Bioconjug Chem; 2013 Dec; 24(12):2045-57. PubMed ID: 24274056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro.
    Willkomm S; Deerberg A; Heidemann J; Flügge F; Meine J; Hu R; Kretschmer-Kazemi Far R; Restle T
    PLoS One; 2016; 11(1):e0146814. PubMed ID: 26784517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the guide strand 3'-end structure on the gene-silencing potency of asymmetric siRNA.
    Hong SW; Park JH; Yun S; Lee CH; Shin C; Lee DK
    Biochem J; 2014 Aug; 461(3):427-34. PubMed ID: 24800867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.
    Kraynack BA; Baker BF
    RNA; 2006 Jan; 12(1):163-76. PubMed ID: 16301602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo activity of nuclease-resistant siRNAs.
    Layzer JM; McCaffrey AP; Tanner AK; Huang Z; Kay MA; Sullenger BA
    RNA; 2004 May; 10(5):766-71. PubMed ID: 15100431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational analysis of siRNA recognition by the Ago2 PAZ domain and identification of the determinants of RNA-induced gene silencing.
    Kandeel M; Kitade Y
    PLoS One; 2013; 8(2):e57140. PubMed ID: 23441235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 4'-C-aminoalkyl-2'-O-methyl modified RNA and their biological properties.
    Koizumi K; Maeda Y; Kano T; Yoshida H; Sakamoto T; Yamagishi K; Ueno Y
    Bioorg Med Chem; 2018 Jul; 26(12):3521-3534. PubMed ID: 29789208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring directional invasion of serum nuclease into siRNA duplexes by asymmetrical terminal modifications.
    Huang Y; Ma Y; Guo Y; Zou L; Jin H; Zhong L; Wu Y; Zhang L; Yang Z
    ChemMedChem; 2014 Sep; 9(9):2111-9. PubMed ID: 25044832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemically modified siRNAs and miRNAs bearing urea/thiourea-bridged aromatic compounds at their 3'-end for RNAi therapy.
    Kitamura Y; Masegi Y; Ogawa S; Nakashima R; Akao Y; Ueno Y; Kitade Y
    Bioorg Med Chem; 2013 Aug; 21(15):4494-501. PubMed ID: 23791869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Guided Control of siRNA Off-Target Effects.
    Suter SR; Sheu-Gruttadauria J; Schirle NT; Valenzuela R; Ball-Jones AA; Onizuka K; MacRae IJ; Beal PA
    J Am Chem Soc; 2016 Jul; 138(28):8667-9. PubMed ID: 27387838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.